Benzinga | Oct 28, 2021 12:21PM EDT

SVB Leerink Maintains Market Perform on Alnylam Pharmaceuticals, Raises Price Target to $108

SVB Leerink analyst Mani Foroohar maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Market Perform and raises the price target from $104 to $108.